Prescriber's Corner

Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma

Nancy M. Nix, PharmD, BCPS, BCOP, Olivia Burdine, PharmD, and Makeda Walker, PharmD

From St. Joseph’s/Candler Health System–South Carolina Cancer Specialists, Hilton Head, South Carolina; University of Georgia, Athens, Georgia; Mercer University, Atlanta, Georgia

Authors' disclosures of potential conflicts of interest are found at the end of this article.

Nancy M. Nix, PharmD, BCPS, BCOP, St. Joseph’s/Candler Health System–South Carolina Cancer Specialists, PO Box 21824, Hilton Head, SC 29925. E-mail: nixna@sjchs.org


J Adv Pract Oncol 2014;5:294–296 | DOI: 10.6004/jadpro.2014.5.4.7 | © 2014 Harborside Press®


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me